Blog - Page 4076 of 5386

MondayNov 03, 2008 4:28 am

AtriCure, Inc. (NASDAQ: ATRC)

AtriCure, Inc. (NASDAQ: ATRC), a medical device company, is focused on leading the development, manufacturing and selling of novel cardiac surgical ablation systems intended to create precise lesions, or scars, in cardiac tissue. The FDA has approved the AtriCure Isolator® system, including its Isolator SynergyTM ablation clamps, and AtriCure’s multifunctional pen and CoolrailTM linear ablation device, for the destruction of heart tissue during surgical procedures. For further information, visit the Company's web site at www.atricure.com.

MondayNov 03, 2008 4:28 am

Novavax, Inc. (NASDAQ: NVAX)

Novavax, Inc. (NASDAQ: NVAX), a clinical stage biotechnology company, is focused on creating innovative vaccines that target a wide array of infectious diseases using advanced proprietary virus-like particle (VLP) technology. The company produces these VLP based, potent, recombinant vaccines by leveraging new and efficient manufacturing approaches. Novavax’s long-term goal is to be able to deliver a customized vaccine in the midst of an epidemic. For further information, visit the Company's web site at www.novavax.com.

MondayNov 03, 2008 4:28 am

ArQule, Inc. (NASDAQ: ARQL)

ArQule, Inc. (NASDAQ: ARQL), a biotechnology company, is committed to researching and developing next-generation, small-molecule cancer therapeutics. The company’s lead product, ARQ 197, is currently in clinical-stage development. ArQule’s discovery efforts are focused on identifying novel kinase inhibitors that are potent, selective and do not compete with ATP (adenosine triphosphate), an energy source for cells. For further information, visit the Company's web site at www.arqule.com.

MondayNov 03, 2008 4:27 am

NovaDel Pharma, Inc. (AMEX: NVD)

NovaDel Pharma, Inc. (AMEX: NVD), a specialty pharmaceutical company, is focused on developing oral spray formulations of a wide array of marketed therapeutics. NovaMist™, the Company's proprietary technology, allows drugs to be rapidly delivered directly into the bloodstream, which results in faster onset of action and may provide patient benefits in compliance, convenience and safety. Currently, NovaDel's most advanced candidates are designed to treat angina, insomnia, and nausea. For further information, visit the Company's web site at www.novadel.com.

MondayNov 03, 2008 4:27 am

Atna Resources Ltd. (TSX: ATN CN)

Atna Resources Ltd. (TSX: ATN CN) is focusing their efforts on building a successful gold mining company devoted to responsible gold production and the creation of sustainable value for shareholders, employees and communities. The company’s experienced management team is steadfast in integrity and is focused on creating a performance driven culture dedicated to safety and environmental responsibility. For further information, visit the Company's web site at www.atna.com.

MondayNov 03, 2008 4:27 am

NovaBay Pharmaceuticals, Inc. (AMEX: NBY)

NovaBay Pharmaceuticals, Inc. (AMEX: NBY) has focused their efforts on developing innovative product candidates that target the treatment or prevention of a broad array of infections in hospital and community environments. Because of the rapid increase in infectious microbes that are resistant to current drugs, many of these infections have become increasingly difficult to treat. Vitro and in vivo tests have proven that the company’s compounds kill a broad range of bacteria, viruses and other infection causing microbes, even those that are resistant to multiple antibiotics. For further information, visit the Company's web site at www.novabaypharma.com.

MondayNov 03, 2008 4:26 am

Athabasca Potash Inc. (TSX: API CN)

Athabasca Potash Inc. (TSX: API CN) is focused on the exploration of potash projects in Saskatchewan, Canada. The company’s Burr Project is being explored aggressively. Athabasca aims to provide shareholders with an exceptional investment opportunity by establishing the company as a pre-eminent Canadian public resource company engaged solely on potash exploration and development. Currently, Athabasca holds 23 potash exploration permits averaging about 1,700,000 acres in Saskatchewan. For further information, visit the Company's web site at www.athabascapotash.ca.

MondayNov 03, 2008 4:26 am

North Shore Acquisition Corporation (OTC BB: NSAQ)

North Shore Acquisition Corporation (OTC BB: NSAQ) was formed on June 26, 2007 to serve as a vehicle to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or other similar business combination with one or more operating businesses or assets. Their efforts in identifying a prospective target business will not be limited to a particular industry. Barry Gordon serves as North Shore’s President and CEO and brings a wealth of experience and an aggressive business style with him.

MondayNov 03, 2008 4:26 am

Asia Time Corporation (AMEX: TYM)

Asia Time Corporation (AMEX: TYM) operates Financial Profiles, an independent investor relations and financial communications firm. Financial Profiles helps clients effectively communicate with investors and other stakeholders, prepare for earnings announcements and important corporate developments, enhance corporate visibility, conduct capital markets transactions and manage crisis situations. The company also provides customized communications counsel and services to public and pre-IPO companies.

MondayNov 03, 2008 4:25 am

Northern Star Mining Corporation (TSX: NSM CN)

Northern Star Mining Corporation (TSX: NSM CN), an aggressive exploration company based in Quebec, Canada, has its focus on its primary project, the Midway property, which is well positioned within the heart of the renowned and prolific Abitibi Gold Belt of Northwestern Quebec, Canada. To date, total gold produced in the Abitibi camp is in excess of 60 million ounces. The Midway property has been extensively drilled over the past two years and continues to show evidence of a significant deposit. For further information, visit the Company's web site at www.nsmgold.com.

Site Search

Company Search

AtriCure, Inc. (NASDAQ: ATRC)

Novavax, Inc. (NASDAQ: NVAX)

ArQule, Inc. (NASDAQ: ARQL)

NovaDel Pharma, Inc. (AMEX: NVD)

Atna Resources Ltd. (TSX: ATN CN)

NovaBay Pharmaceuticals, Inc. (AMEX: NBY)

Athabasca Potash Inc. (TSX: API CN)

North Shore Acquisition Corporation (OTC BB: NSAQ)

Asia Time Corporation (AMEX: TYM)

Northern Star Mining Corporation (TSX: NSM CN)

Market Basics

Newsletter Publishers

Public Companies